Correlation Between Invivyd and Insight Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Invivyd and Insight Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invivyd and Insight Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invivyd and Insight Molecular Diagnostics, you can compare the effects of market volatilities on Invivyd and Insight Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invivyd with a short position of Insight Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invivyd and Insight Molecular.

Diversification Opportunities for Invivyd and Insight Molecular

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Invivyd and Insight is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and Insight Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insight Molecular and Invivyd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invivyd are associated (or correlated) with Insight Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insight Molecular has no effect on the direction of Invivyd i.e., Invivyd and Insight Molecular go up and down completely randomly.

Pair Corralation between Invivyd and Insight Molecular

Given the investment horizon of 90 days Invivyd is expected to generate 1.58 times more return on investment than Insight Molecular. However, Invivyd is 1.58 times more volatile than Insight Molecular Diagnostics. It trades about 0.2 of its potential returns per unit of risk. Insight Molecular Diagnostics is currently generating about 0.27 per unit of risk. If you would invest  104.00  in Invivyd on September 3, 2025 and sell it today you would earn a total of  146.00  from holding Invivyd or generate 140.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Invivyd  vs.  Insight Molecular Diagnostics

 Performance 
       Timeline  
Invivyd 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Invivyd are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Invivyd exhibited solid returns over the last few months and may actually be approaching a breakup point.
Insight Molecular 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Insight Molecular Diagnostics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental indicators, Insight Molecular showed solid returns over the last few months and may actually be approaching a breakup point.

Invivyd and Insight Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Invivyd and Insight Molecular

The main advantage of trading using opposite Invivyd and Insight Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invivyd position performs unexpectedly, Insight Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insight Molecular will offset losses from the drop in Insight Molecular's long position.
The idea behind Invivyd and Insight Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world